** Shares of medical equipment maker West Pharmaceutical Services WST.N fall 14.01% to $277.13 premarket
** Co sees 2025 adj profit between $6 and $6.20 per share, missing analysts avg estimate of $7.44 per share - LSEG
** Sees 2025 sales between $2.88 bln and $2.91 bln, below estimates of $3.04 bln
** Posts Q4 adj profit of $1.82 per share vs analysts avg estimate of $1.72 per share
** Posts Q4 sales of $748.8 mln vs analysts avg estimate of $740.47 mln
** In the last 12 months, WST has fallen ~21%
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。